Related Experiment Video
Updated: Jan 28, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Autoantibody testing in idiopathic inflammatory myopathies
Anke Rietveld1, Johan Lim2, Marianne de Visser2
1Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands Anke.Rietveld@radboudumc.nl.
Routine antibody testing aids in classifying idiopathic inflammatory myopathies, offering insights into patient phenotypes, comorbidities, and prognosis. This approach simplifies diagnosis and guides treatment for better patient outcomes.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Idiopathic inflammatory myopathies (IIM) diagnosis traditionally relies on clinical and histological data.
- Myositis-specific and myositis-associated antibodies have revolutionized IIM classification.
- Autoantibody testing is crucial for understanding distinct patient phenotypes and guiding treatment.
Observation:
- Antibody testing offers deeper insights into IIM phenotypes, comorbidities, treatment response, and prognosis.
- It aids in diagnosing atypical weakness patterns, unresolved limb-girdle myopathy, and interstitial lung disease.
- Technical limitations, such as missing antibodies in available tests, can affect interpretation.
Findings:
- Routine autoantibody testing is recommended for suspected idiopathic inflammatory myopathies.
- Testing helps delineate specific IIM subtypes and associated conditions.
- The review focuses on practical applications and interpretation challenges of antibody testing in IIM.
Implications:
- Enhanced diagnostic accuracy and personalized treatment strategies for idiopathic inflammatory myopathies.
- Improved patient stratification for clinical trials and therapeutic development.
- Addressing technical challenges in antibody testing to maximize clinical utility.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

